Fig. 2.

ZEB1 is a potential target of miR-126 in cervical cancer. a. Putative miR-126 binding site in the 3’UTR of ZEB1 was predicted. The mutant position of ZEB1 3’UTR binding site was also shown. b SiHa and Hela cells were co-transfected with ZEB1 3’UTR or ZEB1 3’UTR Mut, as well as miR-126 mimics or miR-NC mimics. Luciferase reporter assay was performed after 48 h of incubation. Data were presented as mean ± SEM. ** P < 0.01